As if shutting the government down in the name of health insurance subsidies wasn’t enough, a federal judge took an axe to another meaningful way to reform American health policy – auditing bad actors ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities hit a record high in the ...

Delicacy and sensuality collided in Pepa Salazar’s latest collection. Moving effortlessly from soft pinks to daring sheers and weaving in floral prints, feathers, lace, and velvet, the designer built ...

‘The Industry Still Doesn’t Want To Play Fair’ — Salt-N-Pepa Turn Their Rock & Roll Hall Of Fame Speech Into A Rallying Cry For Women In Music Salt-N-Pepa AND Outkast joined a handful of fellow rap ...

Salt-N-Pepa has never dodged frankness. Even at their Rock & Roll Hall of Fame induction, the hip-hop pioneers took a moment from celebrating to put the music industry on blast. But along with ...

Hip-hop legends Salt-N-Pepa added one more monumental honor to their mantle with their induction into the Rock & Roll Hall of Fame as the recipients of this year’s Musical Influence Award. Both Cheryl ...

Salt-N-Pepa threw on the multicolored leather jackets from their "Push It" video and brought the crowd at the Rock & Roll Hall of Fame induction ceremony to its feet with a romping rendition of their ...

Pioneering female rap group Salt-N-Pepa, who are in the middle of a dispute over ownership of their masters, used their induction speeches at the Rock and Roll Hall of Fame ceremony on Saturday to ...

Salt-N-Pepa were inducted into the Rock & Roll Hall of Fame on Saturday night, with Missy Elliott leading the tribute to the trailblazing rap duo. During their acceptance speech, Cheryl “Salt” James ...

Shares of Madrigal Pharmaceuticals (MDGL) traded sharply higher for the second straight session on Wednesday after Cantor Fitzgerald upgraded the company, arguing that the commercial rollout of its ...

Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...

Madrigal Pharmaceuticals is reiterated as a Strong Buy, driven by Rezdiffra's rapid US launch and recent European approval. Q2 2025 saw Rezdiffra sales reach $213M and >23,000 patients, with Q3 ...